The cancer center will begin offering the treatment, which targets and destroys the prostate cancer specific biomarker PSMA+, in March, according to a Feb. 18 news release from Providence.
Previously, the treatment has been available only in the lower 48 states, the release said.
Some early-onset colorectal cancers may be caused by exposure to a bacterial toxin within the first 10 years of life,…
Columbus-based Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute has…
New York City-based NewYork-Presbyterian Hospital had the lowest rate of ED visits for cancer patients receiving outpatient chemotherapy between Jan.…
Comments are closed.
